e-learning
resources
ERJ
2014
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Does a single Pseudomonas aeruginosa isolation predict COPD mortality?
Boutou Afroditi K., Raste Yogini, Reid Jeremy, Alshafi Khalid, Polkey Michael I., Hopkinson Nicholas S.
Source:
Eur Respir J 2014; 44: 794-797
Journal Issue:
September
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Boutou Afroditi K., Raste Yogini, Reid Jeremy, Alshafi Khalid, Polkey Michael I., Hopkinson Nicholas S.. Does a single Pseudomonas aeruginosa isolation predict COPD mortality?. Eur Respir J 2014; 44: 794-797
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD.
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020
Can LCI predict new Pseudomonas aeruginosa colonization among CF patients?>
Source: International Congress 2017 – What is the future for paediatric respiratory physiology and sleep?
Year: 2017
Predicting the outcome of respiratory Pseudomonas aeruginosa infection in vivo
Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring
Year: 2017
The independent contribution of
Pseudomonas aeruginosa
infection to long-term clinical outcomes in bronchiectasis
Source: Eur Respir J, 51 (2) 1701953; 10.1183/13993003.01953-2017
Year: 2018
Pseudomonas aeruginosa as an independent predictor of decreased lung function in bronchiectasis
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis
Source: Eur Respir J 2006; 28: 974-979
Year: 2006
Bronchiectasis exacerbations by Pseudomonas aeruginosa: differences and similarities
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018
Pseudomonas aeruginosa and antibiotic resistance in acute exacerbations of COPD (AECOPD)
Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa
Year: 2009
Newly acquired
pseudomonas aeruginosa
in Belgian cystic fibrosis-patients: does the patients‘
P. aeruginosa
genotype correlate with environmental genotypes?
Source: Eur Respir J 2006; 28: Suppl. 50, 485s
Year: 2006
Pseudomonas aeruginosa
drug susceptibility in patients hospitalized with COPD exacerbation and bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 541s
Year: 2001
Inhaled corticosteroid use and its association with Pseudomonas aeruginosa infection in COPD
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021
Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018
Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study
Source: Eur Respir J 2009; 34: 1072-1078
Year: 2009
Risk factors and outcomes of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa: a clinical case-control study
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017
Pseudomonas aeruginosa isolates in bronchiectasis: Wath particulaties and risk factors?
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Enterobacteriaceae and Pseudomonas aeruginosa in community-acquired pneumonia: the reality after a decade of uncertainty?
Source: Eur Respir J 2010; 35: 473-474
Year: 2010
Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients
Source: Eur Respir J 2008; 31: 822-829
Year: 2008
Omics-based tracking of
Pseudomonas aeruginosa
persistence in “eradicated” cystic fibrosis patients
Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020
Year: 2021
Does Pseudomonas aeruginosa infection alter sputum viscoelastic properties in bronchiectasis patients?
Source: International Congress 2018 – Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques
Year: 2018
Inhaled phage therapy for the treatment of acute Pseudomonas aeruginosa lung infections
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept